Artemether-Lumefantrine Effectiveness in Guinea-Bissau 2
- Conditions
- Malaria
- Registration Number
- NCT01133314
- Lead Sponsor
- Bandim Health Project
- Brief Summary
The routine treatment of children with antimalarials will be monitored. Children with a positive malaria film and/or a positive rapid diagnostic test (RDT) will have a capillary blood sample taken to verify the diagnosis and to monitor the pattern of resistance.
- Detailed Description
Children from Bissau seeking medical advice and who are recommended treatment for malaria in accordance with the current routines will be included as follows:
All children getting the clinical diagnosis of malaria will be registered and basic information collected.
All children with a positive malaria film and/or a positive RDT will be asked for a capillary blood sample (app. 50 - 100 microliters on a filterpaper). Using PCR the parasitological diagnosis will be verified and if parasites are identified the resistance patterns will be examined. Both the capillary blood samples and the RDTs (if taken by the health staff) will be used in order to examine whether the RDTs can be used for routine monitoring of resistance in an area.
The study does not interfere in the routine treatment of the health staff. None of the children will be followed.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 600
- Children seeking a health centre and by the health staff given the diagnosis: malaria and/or being treated with an antimalarial.
- Children where the parents do not accept to participate in the study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of children treated for malaria with a parasitological confirmed malaria. 6 weeks The blood samples will be analysed for parasites at the end of the study. The results do not have any impact on the treatment of the children.
- Secondary Outcome Measures
Name Time Method Percentage of the parasites with mutations coding for resistance to antimalarials. 2 years
Trial Locations
- Locations (1)
Bandim Health Project
🇬🇼Bissau, Bissau Codex, Guinea-Bissau